Ezatollah Ghasemi

Ezatollah Ghasemi

Auto-generated profile, based on publicly available information

Ezatollah Ghasemi

Department of Medical Parasitology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Ultrasonics Sonochemistry
Verified
Journal Article
Open access
RAReza Abazari
Reza Abazari
AMAli Reza Mahjoub
Ali Reza Mahjoub
SMSoheila Molaei
Soheila Molaei
FGFatemeh Ghaffarifar
Fatemeh Ghaffarifar
EGEzatollah Ghasemi
Ezatollah Ghasemi
CCCameron L. Carpenter-Warren
Cameron L. Carpenter-Warren
In this work, a magnetic bio-metal-organic framework (MBMOF) nanocomposite with porous-layer open morphology is synthesized through a simple sonochemical approach and its effects on Leishmania major (MRHO/IR/75/ER) under both in vitro and in vivo conditions are investigated. The effects of sonication time, initial concentration of reagents and sonication power on size and morphology of MBMOF nanocomposites have been investigated and optimized. A comparison was then made between the structural information of the nanostructures and that of the bio-metal-organic framework crystals. Using the powder X-ray diffraction (PXRD), field emission scanning electron microscope (FE-SEM), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FTIR), energy dispersive analysis of X-ray (EDAX), vibrating sample magnetometer (VSM), thermogravimetric analysis (TGA), and Brunauer-Emmet-Teller (BET) techniques, the prepared MBMOF nanocomposites were characterized. The mean numbers of promastigotes (cell/ml) in different MBMOF concentrations (3.12, 6.25, 12.5, 25, 50, 100, 200 and 400 µg mL-1) were determined by direct counting after 24, 48 and 72 h. Using MTT assays, the cytotoxic impacts of the MBMOF nanocomposites on promastigotes, intracellular amastigotes, and J774 macrophages were estimated. In order to investigate their therapeutic effects, the prepared MBMOF nanocomposites (25 and 12.5 µg mL-1) were used as ointment three times a week to treat Leishmania major in BALB/c mice. The lesion size and weight of mice were assessed before and during the treatment. The parasitic loads were measured in spleen and liver through the culture. After 72 h, the INF-γ and IL-4 cytokines levels in the supernatant of the spleen culture were measured. To the best of the authors' knowledge, this study is the first to attempt to synthesize the bio-MOFs through an in-situ sonosynthesis route under ultrasound irradiation and examine their cytotoxicity effects on Leishmania major under in vitro and in vivo conditions.

1 December 2019 in Microbial Pathogenesis
Verified
Journal Article
Closed access
ANAzar Najafi
Azar Najafi
MNMohammad Reza Chaechi Nosrati
Mohammad Reza Chaechi Nosrati
EGEzatollah Ghasemi
Ezatollah Ghasemi
ZNZahra Navi
Zahra Navi
AYAli Yousefi
Ali Yousefi
Mahdi FakharMahdi Fakhar
Mahdi Fakhar

1 July 2021 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
AAAli Asghari
Ali Asghari
SSSadegh Shamsinia
Sadegh Shamsinia
HNHassan Nourmohammadi
Hassan Nourmohammadi
HMHamidreza Majidiani
Hamidreza Majidiani
MFMohammad Fatollahzadeh
Mohammad Fatollahzadeh
MSMorteza Shams
Morteza Shams

1 January 2016
Verified
Journal Article
Open access
MHMohammad Hossein Feiz Haddad
Mohammad Hossein Feiz Haddad
EGEzatollah Ghasemi
Ezatollah Ghasemi
SMSharif Maraghi
Sharif Maraghi
MTMehdi Tavala
Mehdi Tavala
Background: The incidence of cutaneous leishmaniasis in the city of Mehran has risen sharply in recent years because the city borders Iraq, which has allowed entrance of different Leishmania strains. These strains have different shapes, periods of disease, and healing of lesions. The present study identified and determined cutaneous leishmaniasis species in this region. Methods: This cross-sectional study was carried out by preparing slides from 92 patients with suspected cutaneous leishmaniasis lesions from Mehran during 2012-2013. Parasite genomic DNA was extracted and CSB2XF and CSB1XR primers were used to amplify the Leishmania minicircle kDNA regions. The parasite species were detected by specific 13Z and LIR primers by applying nested PCR technique. Results: All banding patterns were diagnosed as L. major parasite by comparison of standard models with amplified fragments 560 bp in length from bands. The patients were 56.5% male and 43.5% female. The most frequently-infected age group was the 21-30 years group at a rate of 27.2%. About 56.3% of patients had a single lesion and a significant correlation was observed between age and number of lesions (P > 0.05). Conclusion: The nested PCR technique was shown to be an effective method with high sensitivity and specificity for identification of human Leishmania parasites. Molecular analysis revealed that parasites isolated from Mehran were identified as L. major and the disease was rural in form.

1 September 2019
Verified
Journal Article
Open access
PDF file
EGEzatollah Ghasemi
Ezatollah Ghasemi
FGFatemeh Ghaffarifar
Fatemeh Ghaffarifar
ADAbdolhossein Dalimi
Abdolhossein Dalimi
JSJavid Sadraei
Javid Sadraei
This study aimed to evaluate the antileishmanial efficacy of oxaliplatin against Leishmania major both in-vitro and in-vivo. The IC50, CC50, and SI of oxaliplatin against promastigotes, murine macrophages, Raw 264.7 cells, and intramacrophage amastigotes of L. major were investigated in-vitro. The effects of this drug on intracellular amastigotes were also assayed, and the percentage of infectivity and IIR were calculated. Flow cytometry was performed to assay apoptosis, using 50 and 100 µg/mL of oxaliplatin in the promastigotes and macrophages. In-vivo, the BALB/c mice were classified into three groups, receiving oxaliplatin, glucantime, and phosphate-buffered saline for one month, respectively. The lesion size, IFN-γ, and IL-4 levels, and parasite burden were also evaluated in the animals. After 72 h, the IC50 and CC50 of oxaliplatin against promastigotes and macrophages were respectively 0.5 and 66.78 µg/mL. The apoptosis of promastigotes and macrophages using 50 µg/mL of oxaliplatin was 7.25% and 2.14%, respectively, while apoptosis induced at 100 µg/mL was 15.48% and 2.80%, respectively. Similar to the glucantime group, the mice treated with oxaliplatin showed a lower parasite burden and smaller lesions, compared with the PBS group (p < 0.01). Furthermore, higher IFN-γ levels were reported in mice receiving oxaliplatin in comparison with those receiving PBS (p < 0.01). The current findings indicated the efficacy of oxaliplatin against promastigote and amastigote forms of Leishmania and L. major-inducedleishmaniasis.

8 November 2016 in Jundishapur Journal of Natural Pharmaceutical Products
Verified
Journal Article
Open access
PDF file
FGFatemeh Ghaffarifar
Fatemeh Ghaffarifar
PEParisa Ebrahimisadr
Parisa Ebrahimisadr
HMHamidreza Majidiani
Hamidreza Majidiani
FBFarahnaz Bineshian
Farahnaz Bineshian
FJFarnoosh Jameie
Farnoosh Jameie
EGEzatollah Ghasemi
Ezatollah Ghasemi
Background: Cutaneous Leishmaniasis (CL) is a serious threat to many endemic regions of the world, which may lead to some complications such as secondary infections, permanent scars, etc. Although there are available drugs, i.e. pentavalent antimony compounds for the treatment of CL, they are expensive, have side effects and/or there may be some drug-resistant species. Therefore, there is a tantalizing field of study to discover novel compounds against CL. In this study, we evaluated the leishmanicidal effects of Chaerophyllum plant extract on Leishmania major promastigotes in vitro. Methods: In each sterile 96-well plate, a volume of 100 λ of promastigotes was added. The three first wells lacked drug but contained drug solvents. Then, various concentrations of Chaerophyllum extract (6.25, 12.5, 25, 50, 100 and 200 µg/mL) were added to the parasite culture. Subsequently, the percentage of cytotoxicity of promastigotes and J774 macrophages were evaluated by the Microculture Tetrazolium Test (MTT) method. Also, the percentage of J774 macrophage apoptosis was assessed by flow cytometry. Results: The IC50 of Chaerophyllum extract was 80.62 µg/mL after 24 hours. The percentage of cytotoxicity of promastigotes and J774 macrophages after adding Chaerophyllum extract was 91% and 45%, respectively, by MTT. The percentage of apoptosis (early and late apoptosis) in macrophages induced by 50 and 100 μg/mL of Chaerophyllum extract after 24 hours was 0.01%, 0.13%, 0.01% and 0.1%, respectively. Conclusions: According to the MTT test, the concentration of 200 μg/mL of Chaerophyllum extract with 90% cytotoxicity was promising against L. major promastigotes and further studies are recommended to evaluate the effects of this plant.